October 9, 2023
Articles & Publications Prefilled Apiject Injector

Accelerating Access: The Future of Prefilled and Plastic

Bo Kowalczyk, Chief Commercial Officer, and Jon Ellenthal, President, both at ApiJect Systems, discuss the need for greater
fill-finish capacity in the pharmaceutical industry highlighted by the covid-19 pandemic, and how ApiJect’s Blow-Fill-Seal
prefilled injector platform aims to meet this need.

Might interest you

View All
Global Health
Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled Drug Delivery Platforms, Upcoming Webinar Hosted by Xtalks
Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint News provided by Xtalks l Feb 10, 2025, 08:30 ET In this free webinar, learn about...
Prefilled Apiject Injector
Transitioning your Drug Product or Vaccine into a Prefilled BFS Delivery Device
• Develop an understanding of the technical factors involved in transitioning your drug product, including material compatibility, process parameters, and their effects on drug stability and integrity. • Identify and resolve potential issues by utilizing prototyping and feasibility studies to ensure the...
BFS Technology
The Blow-Fill-Seal Process
The Blow-Fill-Seal (BFS) process is a widely used manufacturing technique in the pharmaceutical industry. It involves the simultaneous formation, filling, and sealing of containers, all within a single machine. This seamless and efficient process ensures the integrity and sterility of the final...